Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Inoviv

Accelerating the world’s transition to precision medicine through application of omics technologies to drug development and healthcare.
2018
11-50
London, England, United Kingdom
BiopharmaBiotechnologynologyHealth CareHealth DiagnosticsMedicalMedical DevicePrecision MedicineTherapeutics

Investment Funding

Last Funding Stage

Venture - Series Unknown

Last Funding Date

30-01-2024

Lead Investors

Foresight Group, Entrepreneurs First, Ada Ventures, Hoxton Ventures

Revenue

$1M to $10M

People

Founders